Michelle Zubatch is a sales executive with Liaison Technologies
The Drug Information Association is comprised of over 18,000 professionals and experts in the pharmaceutical and life sciences industry. DIA provides professionals, at all levels and disciplines, access to current information that assists in facilitating member’s career advancement. DIA is a nonprofit organization funded by meeting and membership dues.
Each year, DIA holds an annual member meeting so that professionals across the industry can gather together personally to share innovative ideas to their daily challenges. DIA 2012 was held June 24-28 in Philadelphia PA and was the largest multidisciplinary event involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products.
The theme of this year’s annual meeting was ‘Collaborate to Innovate’. The program was comprised of 22 tracks related to specific areas of member interest where experts shared new industry growth opportunities and innovative ideas required to support those growth initiatives.
‘Collaborate to Innovate’ specifically addressed the need for collaboration among diverse partners to bring new medical products to patients, as well as new concepts that involved the future roles patients would play in the drug development process. Clinical trials help to pinpoint the areas where pharma professionals need to learn more to advance scientific and patient innovation.
While at DIA, I had an opportunity to meet with our current customers and prospective customers so that Liaison Healthcare could be better informed of the challenges they are currently experiencing. It was a great opportunity to share the innovative solutions that Liaison Healthcare is currently implementing across all types and sizes of businesses within the industry.
Another objective was to take away industry knowledge that could be shared with my colleagues who were not able to attend. One session that was of high interest from a strategic perspective was ‘Innovation in R&D and Commercialization Through Big Data Analytics’. EMC was the presenter of the session. EMC is a large systems integrator and member with the SAS Institute. Their presentation provided a use case example of how they are innovating R&D and commercialization through Big Data Analytics by utilizing big data warehouses.
EMC suggested that R&D industry demands are going to require tight coordination of a complex network of partners and information resources. They believe that secure and dynamic collaboration will take place, through blended cloud environments (private, public, community and hybrid), so that data can be analyzed, synthesized and later commercialized for high-performing firms. Clinical and research organizations will utilize their ability to commercialize data to differentiate themselves in the industry and secure a competitive advantage in the marketplace. EMC’s three key areas that will drive R&D and commercial success will be data collaboration, big fast data, and the flexibility the cloud provides for engaging multiple information sources from any where at any time.
In addition to the many informative sessions, the exhibitor showcase was very larger and was primarily comprised of firms serving the Pharma, biotech, and medical devices. Throughout the exhibition hours, many companies provided additional sessions in their booths and at the innovation centers located across the tradeshow flow.